Second Line Capital, LLC Abb Vie Inc. Transaction History
Second Line Capital, LLC
- $371 Billion
- Q4 2024
A detailed history of Second Line Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Second Line Capital, LLC holds 1,162 shares of ABBV stock, worth $249,004. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,162
Previous 1,918
39.42%
Holding current value
$249,004
Previous $379 Million
45.49%
% of portfolio
0.06%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,105Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$37.1 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.2 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$17.1 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$11.1 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.5 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $379B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...